Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GLAXF - Vir Biotechnology: mAbs Gaining Traction After New South African Covid Variant

GLAXF - Vir Biotechnology: mAbs Gaining Traction After New South African Covid Variant

GlaxoSmithKline Plc
  • VIR's sotrovimab is a monoclonal antibody that binds to a highly conserved domain on the SARS-COV2 virus.
  • The emergence of the South African variant has shown why mAbs are still highly relevant to treating covid-19 patients.
  • Vir's current low prices - despite the small spike recently - makes it highly attractive.

For further details see:

Vir Biotechnology: mAbs Gaining Traction After New South African Covid Variant
Stock Information
Company Name: GlaxoSmithKline Plc
Stock Symbol: GLAXF
Market: OTC
Website: gsk.com
Menu
GLAXF GLAXF Quote GLAXF Short GLAXF News GLAXF Articles GLAXF Message Board
Get GLAXF Alerts

News, Short Squeeze, Breakout and More Instantly...